Sorafenib Tablet, Film Coated
Product Images NDC 51407-760

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 51407-760). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-760-12 Rev 04-23.jpg (51407 760 12 Rev 04 23)

NDC 51407-760-12 is a prescription medication in the form of film-coated tablets containing 200 mg of sorafenib equivalent to 274 mg of sorafenib tosylate. The medication should be dispensed with patient information printed from https://gsms.us/, and dosage instructions are provided in the accompanying prescribing information. The tablets should be stored in a dry place, away from children, at a temperature of 20-25°C and excursions between 15-30°C. The medication is marketed by GSMS, Incorporated.*

FDA Label Image

Fig (Fig1)

This is a survival analysis chart for Sorafenib versus Placebo in the treatment of cancer. The chart shows the median survival time for Sorafenib to be 10.7 months for 299 patients while the median survival time for Placebo is 7.9 months for 303 patients. The Hazard Ratio (HR) is 0.69, which indicates that patients treated with Sorafenib have a 31% lower risk of death than those on Placebo. The p-value is 0.00058, revealing statistical significance. The x-axis shows months from randomization while the y-axis displays the number of patients at risk. The graph shows the survival rates of Sorafenib to be higher when compared with Placebo.*

FDA Label Image

Figure3 (Fig3)

This appears to be a chart showing the duration of Progression-Free Survival (in months) and the number of patients at risk at each time point for two different groups (Somfonb and Placebo). There are also some strange non-English characters which are likely errors.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structural Formula Of Sorafenib Tosylate (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.